Literature DB >> 16388096

Ghrelin reduces voltage-gated potassium currents in GH3 cells via cyclic GMP pathways.

Xue Feng Han1, Yun Long Zhu, Maria Hernandez, Damien J Keating, Chen Chen.   

Abstract

Ghrelin is an endogenous growth hormone secretagogue (GHS) causing release of GH from pituitary somatotropes through the GHS receptor. Secretion of GH is linked directly to intracellular free Ca(2+) concentration ([Ca(2+)]i), which is determined by Ca(2+) influx and release from intracellular Ca(2+) storage sites. Ca(2+) influx is via voltage-gated Ca(2+) channels, which are activated by cell depolarization. Membrane potential is mainly determined by transmembrane K(+) channels. The present study investigates the in vitroeffect of ghrelin on membrane voltage-gated K(+) channels in the GH3 rat somatotrope cell line. Nystatin-perforated patch clamp recording was used to record K(+) currents under voltage-clamp conditions. In the presence of Co(2+) (1 mM, Ca(2+) channel blocker) and tetrodotoxin (1 microM, Na(+) channel blocker) in the bath solution, two types of voltage-gated K(+) currents were characterized on the basis of their biophysical kinetics and pharmacological properties. We observed that transient K(+) current (IA) represented a significant proportion of total K(+) currents in some cells, whereas delayed rectifier K(+) current (IK) existed in all cells. The application of ghrelin (10 nM) reversibly and significantly decreased the amplitude of both IA and IK currents to 48% and 64% of control, respectively. Application of apamin (1 microM, SK channel blocker) or charybdotoxin (1 microM, BK channel blocker) did not alter the K(+) current or the response to ghrelin. The ghrelin-induced reduction in K(+) currents was not affected by PKC and PKA inhibitors. KT5823, a specific PKG inhibitor, totally abolished the K+ current response to ghrelin. These results suggest that ghrelin-induced reduction of voltage-gated K(+) currents in GH3 cells is mediated through a PKG-dependent pathway. A decrease in voltage-gated K(+) currents may increase the frequency, duration, and amplitude of action potentials and contribute to GH secretion from somatotropes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16388096     DOI: 10.1385/ENDO:28:2:217

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  43 in total

1.  The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.

Authors:  M Korbonits; S A Bustin; M Kojima; S Jordan; E F Adams; D G Lowe; K Kangawa; A B Grossman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Somatostatin activates an inwardly rectifying K+ conductance in freshly dispersed rat somatotrophs.

Authors:  S M Sims; B T Lussier; J Kraicer
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

3.  Ghrelin strongly stimulates growth hormone release in humans.

Authors:  K Takaya; H Ariyasu; N Kanamoto; H Iwakura; A Yoshimoto; M Harada; K Mori; Y Komatsu; T Usui; A Shimatsu; Y Ogawa; K Hosoda; T Akamizu; M Kojima; K Kangawa; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

4.  Regulation of the ghrelin gene: growth hormone-releasing hormone upregulates ghrelin mRNA in the pituitary.

Authors:  J Kamegai; H Tamura; T Shimizu; S Ishii; H Sugihara; S Oikawa
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

5.  An inward-rectifying K+ current in clonal rat pituitary cells and its modulation by thyrotrophin-releasing hormone.

Authors:  C K Bauer; W Meyerhof; J R Schwarz
Journal:  J Physiol       Date:  1990-10       Impact factor: 5.182

6.  Growth hormone-releasing peptide-2 reduces inward rectifying K+ currents via a PKA-cAMP-mediated signalling pathway in ovine somatotropes.

Authors:  Ruwei Xu; Yufeng Zhao; Chen Chen
Journal:  J Physiol       Date:  2002-12-01       Impact factor: 5.182

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  On the mechanism of growth hormone autofeedback regulation: possible role of somatostatin and growth hormone-releasing factor.

Authors:  S Conway; S M McCann; L Krulich
Journal:  Endocrinology       Date:  1985-12       Impact factor: 4.736

9.  Involvement of nitric oxide in growth hormone (GH)-releasing hormone-induced GH secretion in rat pituitary cells.

Authors:  M Kato
Journal:  Endocrinology       Date:  1992-11       Impact factor: 4.736

10.  Somatostatin increases voltage-dependent potassium currents in rat somatotrophs.

Authors:  C Chen; J Zhang; J D Vincent; J M Israel
Journal:  Am J Physiol       Date:  1990-12
View more
  5 in total

1.  Ghrelin reduces voltage-gated calcium currents in GH₃ cells via cyclic GMP pathways.

Authors:  Xuefeng Han; Yunlong Zhu; Yufeng Zhao; Chen Chen
Journal:  Endocrine       Date:  2011-08-27       Impact factor: 3.633

2.  Ghrelin stimulates proliferation of human osteoblastic TE85 cells via NO/cGMP signaling pathway.

Authors:  Deng-Hu Wang; Yun-Sheng Hu; Jun-Jie Du; Yun-Yu Hu; Wei-De Zhong; Wei-Jun Qin
Journal:  Endocrine       Date:  2008-10-25       Impact factor: 3.633

3.  Differential gene regulation of GHSR signaling pathway in the arcuate nucleus and NPY neurons by fasting, diet-induced obesity, and 17β-estradiol.

Authors:  Ali Yasrebi; Anna Hsieh; Kyle J Mamounis; Elizabeth A Krumm; Jennifer A Yang; Jason Magby; Pu Hu; Troy A Roepke
Journal:  Mol Cell Endocrinol       Date:  2015-11-11       Impact factor: 4.102

4.  Ghrelin in central neurons.

Authors:  F Ferrini; C Salio; L Lossi; A Merighi
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

5.  Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells.

Authors:  Belisario Domínguez Mancera; Eduardo Monjaraz Guzman; Jorge L V Flores-Hernández; Manuel Barrientos Morales; José M Martínez Hernandez; Antonio Hernández Beltran; Patricia Cervantes Acosta
Journal:  J Biophys       Date:  2013-02-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.